In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids

Clinical and Experimental Immunology

Volumn 105, Issue 1, 1996, Pages 26-30

  Behboudi, S ^a   Morein, B ^a   Villacres Eriksson, M ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

adjuvants; APC; IL 1; iscoms; vaccines

Indexed keywords

ADJUVANT; CHOLERA TOXIN; CYTOKINE; INTERLEUKIN 1; ISCOM; LIPOPOLYSACCHARIDE; MURAMYL DIPEPTIDE; POLYMYXIN B; SAPONIN; TRITERPENOID; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG FORMULATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

QUILLAJA SAPONARIA;

EID: 0030016032     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-730.x     Document Type: Article

References (34)

1. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79:319-26.
2. Durum SK, Schmidt JA, Oppenheim JJ. Interlukine 1: an immunological perspective. Annu Rev Immunol 1985; 3:265-89.
3. Durum SK, Higuchi C, Ron Y. Accessory cells and T cell activation. The relationship between two components of macrophage acessory cell function: 1-A and IL-1. Immunobiology 1984; 168:213-31.
4. Unanue ER, Allen PM. The basis of the immunoregulatory role of macrophages and other accessory cells. Science 1987; 236:551-7.
5. Dinarello CA. Interleukin-1. Rev Infec Dis 1984; 6:51-95.
6. Scala G, Oppenheim JJ. Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1. J Immunol 1983; 131:1160-6.
7. Larsson EL, Iscove NN, Coutinho A. Two distinct factors are required for induction of T-cell growth. Nature 1980; 283:664-6.
8. de Freitas EC, Chesnul RW, Grey HM, Chiller JM. Macrophage-dependent activation of antigen-specific T cells requires antigen and a soluble monokine. J Immunol 1983; 131:23-29.
9. Jampel HD, Duff GW, Gershon RK, Atkins E, Durum SK. Fever and immunoregulation. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med 1983; 157:1229-38.
10. Oppenheim JJ, Togawa A, Chedid L, Mizel S. Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor. Cell Immunol 1980; 50:71-81.
11. Vacheron F, Guenounou M, Neuciel C. Induction of interleukin 1 secretion by adjuvant-active peptidoglycans. Infect Immun 1983; 42:1049-54.
12. Sagara T, Mori S, Ohkawara S, Goto F, Takagi K, and Yoshinaga M. A limited role of IL-1 in immune-enhancement by adjuvants. Immunology 1990;71:251-7.
13. Morein B, Helenius A, Simons R, Pettersson R, Kaarianen L, Schirrmacher V. Effective subunit vaccines against an enveloped animal virus. Nature 1987; 276:715-8.
14. Morein B, Lövgren K, Rönnberg B, Sjölander A, Villacres-Eriksson M. Immunostimulating complex: clinical potential in vaccine development. Clin Immunother 1995; 6:461-75.
15. Villacres-Eriksson M, Bergström-Mollaoglu M, Kåberg H, Morein B. Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms. Scand J Immunol 1992; 36:421-6.
16. Lövgren K. The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand J Immunol 1988; 27:241-5.
17. Villacres-Eriksson M. Antigen presentation by naive macrophages, dendritic cells and B cells to prime T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin Exp Immunol 1995; 102:46-52.
18. Villacres-Eriksson M, Bergström-Mollaoglu M, Kåberg H, Lövgren K, Morein B. The induction of cell-associated and secreted IL-1 by iscoms, matrix and micelles in murine splenic cells. Clin Exp Immunol 1993; 93:120-5.
19. Watson DL, Lövgren K, Watson NA, Fossum C, Morein B, Höglund S. Inflammatory response and antigen localization following immunization with influenza virus iscoms. Inflammation 1989; 13:641-9.
20. Fossum C, Bergström M, Lövgren K, Watson DL, Morein B. Effect of iscom and/or their adjuvant moiety (matrix) on the initial proliferative and IL-2 responses in vitro. Comparison of spleen cells from mice inoculated with iscoms and/ or matrix. Cell Immunol 1990; 129:414-25.
21. Kensil CR, Patel U, Lennick M, Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol 1991; 146:431-7.
22. Rönnberg B, Fekadu M, Morein B. Adjuvant activity of non toxic Quillaja saponaria Molina components for use in iscom-matrix. Vaccine 1995; 14:1375-82.
23. Lövgren K, Morein B. The requirement of lipids for the formation of immunostimulating complexes (iscoms). Biotechnol Appl Biochem 1988; 10:161-72.
24. Lövgren-Bengtsson K, Sjölander A. Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant. Vaccine 1996; in press.
25. Behboudi S, Morein B, Rönnberg B. Isolation and quantification of Quillaja saponaria Molina and lipids in iscom-matrix and iscom. Vaccine. 1995; 17:1690-6.
26. Sceicher C, Mehlig M, Dienes H, Reske K. Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in upregulation of interleukin-1α and interleukin-12 p40/p35 and triggers prolonged efficient antigen presentation. Eur J Immunol 1995; 25:1566-72.
27. Nichols JE, Fitzgerald TF Roberts NJ Jr. Human macrophage responses to vaccine strains of influenza virus: synthesis of viral proteins interleukin-1β interleukin-6 tumour necrosis factor-α and interleukin-1 inhibitor. Vaccine 1993; 11:36-42.
28. Nagao S, Akagawa KS, Yamada K, Yagawa K, Tokunaga T, Kotani S. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptie (MDP). Microbiol Immunol 1990; 34:323-35.
29. Arenzana-Seisdedos F, Virelizier JL, Fiers W. Interferons as macrophage-activating factors. Preferential effects of interferon-γ on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol 1985; 134:2444-8.
30. Damais C, Parant M, Chedid L. Synergistic enhancement of interleukin-1 production by human monocytes stimulated with gamma- interferon and MDP. J Leukocyte Biol 1985; 37:692.
31. Bromander A, Holmgren J, Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol 1991; 146:2908-14.
32. Duff G, Atkins E. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods 1982; 52:333-40.
33. Wood DD, Staruch MJ, Durelte PL, Melvin WV, and Graham BK. Role of interleukin-1 in the adjuvanticity of muramyl dipeptide in vivo. In: Oppenheim JJ, Cohen S, eds. Proceeding of the Third Internatinal Lymphokine Workshop. New York: Academic Press, 1983:691-8.
34. Schijns VECJ, Claassen IJThM, Vermeulen AA, Horzinek MC, Osterhause ADME. Modulation of antiviral immune response by exogenous cytokines: effects of tumour necrosis factor-α, interleukin-1α, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine. J Gen Virol 1994; 75:55-63.